Tatyana Andreyeva - Concepedia

Author

Tatyana Andreyeva

Pfizer (United States)

Also Known As

T. Andreyeva, Tatyana A Andreyeva, Tatyana Andreyeva

Publications

684

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)University of Massachusetts Amherst

About

Tatyana Andreyeva is an author at Pfizer (United States) specializing in medicine, autoimmune disease, and immunodominance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	88
2	Immunology	2	2	88
3	Autoimmune Disease	2	2	88
4	Allergy	1	1	20
5	Cell Biology	1	1	68

Tatyana Andreyeva

Publications

678

Citations

H-Index

Page 1

	Year	Citations
Rab11 GTPase-Regulated Membrane Trafficking Is Crucial for Tip-Focused Pollen Tube Growth in Tobacco Barend H. J. de Graaf, Alice Y. Cheung, Tatyana Andreyeva, The Plant Cell	2005	192
Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis Andrew L. Rankin, Nilufer P. Seth, Sean Keegan, The Journal of Immunology	2013	108
The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial Aaron Winkler, Weiyong Sun, Saurav De, Arthritis & Rheumatology	2021	86
Regulation of pollen tube growth by Rac-like GTPases Alice Y. Cheung, Christine Y.-h. Chen, Lizhen Tao, Journal of Experimental Botany	2003	72
IL-21 Receptor Is Critical for the Development of Memory B Cell Responses Andrew L. Rankin, Heather MacLeod, Sean Keegan, The Journal of Immunology Lymphocyte DevelopmentAdaptive Immune SystemHumoral ResponseImmunologyImmune Regulation	2010	68
MyD88 Is Required for the Formation of Long-Term Humoral Immunity to Virus Infection Heath Guay, Tatyana Andreyeva, Robert L. Garcea, The Journal of Immunology	2007	63
In vitro potency, pharmacokinetic profiles and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus Yulia Vugmeyster, Heath Guay, Pamela Szklut, mAbs	2010	49
Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model Joanne Brodfuehrer, Andrew L. Rankin, Jason Edmonds, Pharmaceutical Research AllergyAutoimmune DiseaseCxcl13 Neutralizing AntibodyQuantitative AnalysisImmunology	2013	20
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+ T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation Wěi Li, Kimberly Crouse, Jennifer Alley, Journal of Pharmacology and Experimental Therapeutics	2023	20

Page 1